Newsletter | April 11, 2026

04.11.26 -- Life Science Leader Best Of March

MARCH'S BEST FEATURED EDITORIAL

The Human Variable: The Leadership Risk Biotech Governance Still Ignores

The mental faculties a biotech CEO needs most are the first to degrade under chronic pressure. This is not a character issue, it's physiological, writes Maria Bostock.

MARCH'S BEST INDUSTRY INSIGHTS

Biopharma Reaping Numerous Benefits From AI

Many challenges can stall advanced therapy’s development, and most of them are tied to inadequate preclinical planning and partner vetting. Find how to foster a better development strategy.

Four Challenges That Stall Advanced Therapy Development

Many challenges can stall an advanced therapy’s development, and the vast majority of them are tied to inadequate preclinical planning and partner vetting. Find how to foster a better development strategy.

Your Essential Guide To Clinical Trial Payments And Ethics

Fair compensation in trials requires distinguishing reimbursement from stipends. Learn the ethical principles that ensure payments uphold participant respect and remove financial barriers.

Connect With Life Science Leader: